20299-31-4 Usage
Uses
Used in Pharmaceutical Research and Development:
3-(4-acetylphenyl)-2-aminopropanoic acid hydrochloride is utilized as a research compound for exploring its potential medicinal properties. Its structural relation to other amino acids suggests it may act as an inhibitor of certain enzymes or receptors in the body, offering new avenues for drug discovery and development.
Used in Drug Discovery:
In the drug discovery industry, 3-(4-acetylphenyl)-2-aminopropanoic acid hydrochloride is employed as a lead compound for the development of new pharmaceuticals. Its unique structure and potential inhibitory effects on biological targets make it a promising candidate for further investigation and optimization to treat various diseases and conditions.
Used in Enzyme or Receptor Inhibition Studies:
3-(4-acetylphenyl)-2-aminopropanoic acid hydrochloride is used as a tool compound in studies aimed at understanding its interaction with specific enzymes or receptors. This knowledge can contribute to the development of targeted therapies and a better understanding of the compound's mechanism of action in biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 20299-31-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,2,9 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 20299-31:
(7*2)+(6*0)+(5*2)+(4*9)+(3*9)+(2*3)+(1*1)=94
94 % 10 = 4
So 20299-31-4 is a valid CAS Registry Number.
20299-31-4Relevant academic research and scientific papers
Streefkerk, Dieuwertje E.,Schmidt, Marcel,Ippel, Johannes H.,Hackeng, Tilman M.,Nuijens, Timo,Timmerman, Peter,Van Maarseveen, Jan H.
, p. 2095 - 2100 (2019)
In Nature, multicyclic peptides constitute a versatile molecule class with various biological functions. For their pharmaceutical exploitation, chemical methodologies that enable selective consecutive macrocyclizations are required. We disclose a combination of enzymatic macrocyclization, CLIPS alkylation, and oxime ligation to prepare tetracyclic peptides. Five new small molecular scaffolds and differently sized model peptides featuring noncanonical amino acids were synthesized. Enzymatic macrocyclization, followed by one-pot scaffold-assisted cyclizations, yielded 21 tetracyclic peptides in a facile and robust manner.
